Insights

Gathering insights about Whimsical…

Similar companies to Whimsical

Whimsical Tech Stack

Media & News

Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025
Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU Rapid and sustained efficacy regardless of baseline IgE levels in patients with CSU
Sep 17, 2025 | www.globenewswire.com
Constellation Software Inc. Announces Conference Call to Discuss AI's Impact on Software Businesses
TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or “CSI”) announced today it will host a live shareholder question and answer audio webcast on September 22, 2025 at 9:00 a.m. ET. regarding the impact of Artificial Intelligence technologies (“AI”) on software businesses.
Sep 16, 2025 | www.globenewswire.com
Constellation Software Inc. Announces Results for the Second Quarter Ended June 30, 2025 and Declares Quarterly Dividend
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the second quarter ended June 30, 2025 and declared a $1.00 per share dividend payable on October 10, 2025 to all common shareholders of record at close of business on September 19, 2025. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated.
Aug 08, 2025 | www.globenewswire.com
Constellation Software Inc. Announces Release Date for Second Quarter Results
TORONTO, July 14, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) announced today it intends to release its second quarter results on August 8, 2025.
Jul 14, 2025 | www.globenewswire.com
Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2025 and declared a $1.00 per share dividend payable on July 11, 2025 to all common shareholders of record at close of business on June 20, 2025. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated.
May 12, 2025 | www.globenewswire.com
Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved Paris and Tarrytown, NY, April 18, 2025. The US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) antihistamine treatment.
Apr 18, 2025 | www.globenewswire.com
Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite antihistamine treatment CSU is the seventh disease with underlying type 2 inflammation in which Dupixent is approved TARRYTOWN, N.Y. and PARIS, April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved Dupixent® (dupilumab) for the treatment of adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) antihistamine treatment.
Apr 18, 2025 | www.globenewswire.com

Whimsical's Email Address Formats

Whimsical uses at least 1 format(s):

Whimsical Email Formats	Example	Percentage
FirstLast@alpeventhire.co.uk	JohnDoe@alpeventhire.co.uk	47%
FirLast@alpeventhire.co.uk	JohDoe@alpeventhire.co.uk	3%
FirstLas@alpeventhire.co.uk	JohnDoe@alpeventhire.co.uk	3%
FirstLast@alpeventhire.co.uk	JohnDoe@alpeventhire.co.uk	47%

Frequently Asked Questions

What is Whimsical's stock symbol?

Whimsical is a publicly traded company; the company's stock symbol is CSU.

What is Whimsical's official website and social media links?

Whimsical's official website is alpeventhire.co.uk and has social profiles on LinkedIn.

What is Whimsical's SIC code NAICS code?

Whimsical's SIC code is 7389 - Business Services, Not Elsewhere Classified NAICS code is 56192 - Convention and Trade Show Organizers.

How many employees does Whimsical have currently?

As of March 2026, Whimsical has approximately 2.1K employees across 5 continents, including EuropeAsiaAfrica. Key team members include Director Of Cloud & Hosting: A. G.Managing Director: E. O.Document Controller: T. D.. Explore Whimsical's employee directory with LeadIQ.

What industry does Whimsical belong to?

Whimsical operates in the Events Services industry.

What is Whimsical's email format?

Whimsical's email format typically follows the pattern of FirstLast@alpeventhire.co.uk. Find more Whimsical email formats with LeadIQ.

When was Whimsical founded?

Whimsical was founded in 2011.

Whimsical

Q: What is Whimsical's official website and social media links?

Whimsical's official website is alpeventhire.co.uk. Whimsical has social profiles on LinkedIn.

Q: How many employees does Whimsical have currently?

Whimsical has approximately 2.1K employees.

Events Services1001-5000 Employees

We are an 'All Under One Roof Production House' 
Wether you require a simple Dry Hire of Professional Audio, Lighting or AV equipment through to Full Production Management, Theatre Set Building, Festival Stages, Giant LED Screens, Generators, Power Distribution, Catering Hire, Furniture Hire, Marquee Hire, Bar Hire, Cookery Theatre Hire, WC Hire, Theming and Prop Hire we stock it all, please contact us for more information.

Company Overview

Website: alpeventhire.co.uk
SIC Code: 7389 - Business Services, Not Elsewhere Classified
Stock Symbol: CSU
NAICS Code: 56192 - Convention and Trade Show Organizers
Founded: 2011
Employees: 1001-5000

Media & News

Funding & Financials

$100M$250M
Whimsical's revenue is estimated to be in the range of $100M$250M

Funding & Financials

$100M$250M
Whimsical's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Whimsical

TP

TTEC

Alorica

Foundever

Startek

Conduent

IBEX Global

wipro

Whimsical Tech Stack

Media & News

Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025

Constellation Software Inc. Announces Conference Call to Discuss AI's Impact on Software Businesses

Constellation Software Inc. Announces Results for the Second Quarter Ended June 30, 2025 and Declares Quarterly Dividend

Constellation Software Inc. Announces Release Date for Second Quarter Results

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Whimsical's Email Address Formats

Frequently Asked Questions

What is Whimsical's stock symbol?

What is Whimsical's official website and social media links?

What is Whimsical's SIC code NAICS code?

How many employees does Whimsical have currently?

What industry does Whimsical belong to?

What is Whimsical's email format?

When was Whimsical founded?

Whimsical

Company Overview

Media & News

Celldex Presents Data Demonstrating Barzolvolimab Improves Chronic Spontaneous Urticaria Independent of Baseline Immunoglobulin E levels in Phase 2 Study at EADV Congress 2025

Constellation Software Inc. Announces Conference Call to Discuss AI's Impact on Software Businesses

Constellation Software Inc. Announces Results for the Second Quarter Ended June 30, 2025 and Declares Quarterly Dividend

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?